{"id":"W3138793908","doi":"10.3390/jcm10061242","title":"Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease","year":2021,"lang":"en","type":"review","venue":"Journal of Clinical Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"Pfizer; Amgen","keywords":"Vedolizumab; Medicine; Tofacitinib; Ustekinumab; Therapeutic drug monitoring; Inflammatory bowel disease; Drug; Fingolimod; Tumor necrosis factor alpha; Crohn's disease; Pharmacokinetics; Adalimumab; Intensive care medicine; Pharmacology; Disease; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001656355,0.0005113701,0.001972162,0.0002098711,0.00004255817,0.00002857299,0.0003785084,0.0003625027,0.00004840159],"category_scores_gemma":[0.001349403,0.0003341937,0.0005210941,0.0001197235,0.0003765483,0.00001119856,0.0001120657,0.001131079,0.00000755581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004757778,"about_ca_system_score_gemma":0.001344291,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":8.821252e-7,"about_ca_topic_score_gemma":0.000003167608,"domain_scores_codex":[0.9953076,0.0008411533,0.002444655,0.000512232,0.0005695759,0.0003248335],"domain_scores_gemma":[0.9964669,0.0003116399,0.001618931,0.0006042008,0.0002701568,0.000728119],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003652759,0.000542007,0.04404821,0.009641436,0.001298532,0.01435749,0.00005883274,0.00002251602,0.000004213528,0.0001235501,0.001890179,0.9243603],"study_design_scores_gemma":[0.004787413,0.0007861237,0.03885489,0.03623635,0.001513269,0.0002332937,0.00006752599,0.000002767663,0.00000284335,0.00004042569,0.9169787,0.0004963524],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.05523152,0.9430504,0.00000880197,0.0002477723,0.0009464516,0.0003708616,0.00002055655,0.000005368262,0.0001182882],"genre_scores_gemma":[0.008799861,0.9870275,0.00005865057,0.0003567444,0.003457659,0.0000195444,0.00005222471,0.00007786146,0.0001500174],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9238639,"threshold_uncertainty_score":0.999911,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04688484297190361,"score_gpt":0.3941969818085239,"score_spread":0.3473121388366203,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}